Segra International Corp. is pleased to announce a new exclusive global distribution agreement with Grounded Genetics and The Holding Company. Under the terms of the agreements, Segra will partner with both companies to bring a significant collection of proven, award-winning and unreleased genetics to Canadian and International markets, the company said. Access to these genetics will be available in the fall of 2023 in the form of tissue culture mother plants and tissue culture plantlets (clones).
In addition to their collection, Segra will collaborate with both groups to offer custom phenotype selection and breeding projects for customers on an “a la carte” basis. “We believe that pheno selection and breeding initiatives are better suited in a dedicated environment vs. the grow rooms of our customers. Offering this service fills a gap in the market place and allows our customers to focus on what they do best — cultivation,” said Matthew Don-Carolis, vice-president of sales for Segra.
“I am thrilled to announce our partnership with Grounded Genetics and The Holding Company. Their global reputation and experience in breeding and genetic selection is impressive. Their ability and commitment to identify the best cultivars for specific environments and outcomes aligns perfectly with our mission to deliver exceptional products to our customers,” said Jamie Blundell, CEO of Segra. “Together, we can leverage our collective strengths to refine the cannabis experience and provide unmatched quality and variety in the market. This partnership marks a significant milestone for our companies, and I am excited to embark on this journey of discovery and growth.”
This partnership presents a compelling opportunity to leverage years of innovation and genetic development for growers to introduce true-to-type, proven and diverse cultivars into their respective markets, the partners said.
